Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919360 · ClinicalTrials.gov registry record
Gene Expression In Pregnancies Complicated by Preeclampsia
A clinical trial, sponsored by University of Rochester.
- Terminated
- Registry status
- 125
- Enrollment target
NCT00919360 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 125 participants.
The verdict
NCT00919360 was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not. * This may eventually lead to an understanding of its cause. At this time, there is no known way to prevent preeclampsia, and the cause is not known. * The only treatment is delivery of the baby, even if it is premature, in order to decrease the risk to the mother.
Interventions
- PROCEDURE collection of maternal blood specimen prior to delivery
- PROCEDURE collection of placental cord blood after delivery
- PROCEDURE collection of placental tissue
- PROCEDURE collection of strip of decidua from uterine lining from cesarean section deliveries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2008-06 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00919360
The ClinicalTrials.gov registry entry for NCT00919360 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which collection of maternal blood specimen prior to delivery is the first listed.
NCT00919360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00919360 about?
NCT00919360 is a clinical study titled "Gene Expression In Pregnancies Complicated by Preeclampsia". The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not. * This may eventually lead to an understanding of its cause. At this time, there is no known way to prevent preeclampsia, and the cause is not known. * The...
What is the current status of trial NCT00919360?
This trial is currently terminated. The enrollment target is 125 participants. The study started on 2008-06. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00919360?
The interventions under investigation include: collection of maternal blood specimen prior to delivery (PROCEDURE), collection of placental cord blood after delivery (PROCEDURE), collection of placental tissue (PROCEDURE), collection of strip of decidua from uterine lining from cesarean section deliveries (PROCEDURE).
Who is sponsoring clinical trial NCT00919360?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.